The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The index has shown a price loss of -24.89% this year. Over the last six months, there has been a stronger performance of -23.67%. The price of EVH leaped by -8.85% during the last 30 days period. For the last 5-days stocks have improved 3.17%.
Evolent Health Inc’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $33.63 on 08/26/24, and the lowest price during the same period was recorded at $7.06 on 05/23/25.
52-week price history of EVH Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Evolent Health Inc’s current trading price is -74.87% away from its 52-week high, while its distance from the 52-week low is 19.69%. The stock’s price range for this period has been between $7.06 and $33.63. The Healthcare sector company’s shares saw a trading volume of about 2.39 million for the day, which was higher than the average daily volume of 2.25 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Evolent Health Inc (EVH) has experienced a quarterly decline of -11.43% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 992.02M and boasts a workforce of 4500 employees.
How Moving Averages and Trading Volume Data Work Together
EVH’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for EVH stands at 1.14. Similarly, the long-term debt-to-equity ratio is also 0.92.
